MX2016003566A - Composicion que contiene polietilen glicol. - Google Patents
Composicion que contiene polietilen glicol.Info
- Publication number
- MX2016003566A MX2016003566A MX2016003566A MX2016003566A MX2016003566A MX 2016003566 A MX2016003566 A MX 2016003566A MX 2016003566 A MX2016003566 A MX 2016003566A MX 2016003566 A MX2016003566 A MX 2016003566A MX 2016003566 A MX2016003566 A MX 2016003566A
- Authority
- MX
- Mexico
- Prior art keywords
- polyethylene glycol
- containing composition
- salt
- formula
- pharmaceutical composition
- Prior art date
Links
- 239000002202 Polyethylene glycol Substances 0.000 title abstract 2
- 229920001223 polyethylene glycol Polymers 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dermatology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013195329 | 2013-09-20 | ||
| PCT/JP2014/074698 WO2015041294A1 (ja) | 2013-09-20 | 2014-09-18 | ポリエチレングリコール含有組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016003566A true MX2016003566A (es) | 2016-06-02 |
Family
ID=52688941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016003566A MX2016003566A (es) | 2013-09-20 | 2014-09-18 | Composicion que contiene polietilen glicol. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20160228420A1 (enExample) |
| EP (1) | EP3047850A4 (enExample) |
| JP (2) | JP5856264B2 (enExample) |
| KR (1) | KR20160060656A (enExample) |
| CN (1) | CN105555271A (enExample) |
| AU (1) | AU2014322111A1 (enExample) |
| BR (1) | BR112016006153A2 (enExample) |
| CA (1) | CA2924628A1 (enExample) |
| EA (1) | EA201690621A1 (enExample) |
| HK (2) | HK1221407A1 (enExample) |
| IL (1) | IL244648A0 (enExample) |
| MX (1) | MX2016003566A (enExample) |
| MY (1) | MY163236A (enExample) |
| PH (1) | PH12016500461A1 (enExample) |
| SG (1) | SG11201602020QA (enExample) |
| TW (1) | TW201518291A (enExample) |
| WO (1) | WO2015041294A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9987368B2 (en) | 2015-03-17 | 2018-06-05 | Santen Pharmaceutical Co., Ltd. | Pharmaceutical composition comprising polypeptide |
| CA2979971A1 (en) * | 2015-03-18 | 2016-09-22 | Santen Pharmaceutical Co., Ltd. | Sustained-release pharmaceutical composition |
| JP2017008047A (ja) * | 2015-06-25 | 2017-01-12 | 参天製薬株式会社 | 注射剤 |
| JP6872322B2 (ja) * | 2015-07-01 | 2021-05-19 | 参天製薬株式会社 | クエン酸エステルを含有するデポ剤 |
| CN106902117A (zh) * | 2015-12-23 | 2017-06-30 | 瑞阳(苏州)生物科技有限公司 | 一种预防或治疗脉络膜新生血管形成的药物 |
| US10772885B2 (en) | 2016-09-26 | 2020-09-15 | Reyoung (Suzhou) Biology Science & Technology Co., Ltd. | Composition for treating ocular diseases and methods of usage and making |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA833692B (en) * | 1982-05-28 | 1985-02-27 | Beecham Group Plc | Pharmaceutical formulations |
| JPS59101478A (ja) * | 1982-11-29 | 1984-06-12 | Sunstar Inc | リグスチライドを安定に配合した水系組成物 |
| JPH09110698A (ja) * | 1995-10-19 | 1997-04-28 | Taiho Yakuhin Kogyo Kk | 経口用医薬組成物の製造法 |
| KR101179840B1 (ko) * | 2004-02-17 | 2012-09-04 | 산텐 세이야꾸 가부시키가이샤 | 치환 또는 무치환 아미노기를 도입한 4-피리딜알킬티오기를갖는 신규 고리형 화합물 |
| JP4626353B2 (ja) * | 2004-02-17 | 2011-02-09 | 参天製薬株式会社 | 置換又は無置換アミノ基を導入した４−ピリジルアルキルチオ基を有する新規環式化合物 |
| ES2368153T3 (es) * | 2004-02-17 | 2011-11-14 | Santen Pharmaceutical Co., Ltd. | Nuevo compuesto cíclico que presenta un grupo 4-piridilalquiltio que presenta amino (no) sustituido introducido en el mismo. |
| US20060153920A1 (en) * | 2004-09-24 | 2006-07-13 | Ketan Amin | Lyophilized pharmaceutical compositions |
| GB2438544A (en) | 2005-02-09 | 2007-11-28 | Cooper Internat Corp | Liquid formulations for treatment of diseases or conditions |
| US20070149593A1 (en) | 2005-12-23 | 2007-06-28 | Alcon, Inc. | PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
| BRPI0721885A2 (pt) | 2007-07-20 | 2014-02-25 | Alcon Inc | Formulação farmacêutica para distribuição de compostos inibidores de receptores de tirosina quinase (rtki) para os olhos |
| EP2222168B1 (en) * | 2007-11-26 | 2018-09-12 | Merial, Inc. | Solvent systems for pour-on formulations for combating parasites |
| AU2010221438C1 (en) | 2009-03-03 | 2015-01-29 | Alcon Research, Ltd. | Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye |
| MY157122A (en) * | 2009-07-17 | 2016-05-13 | Santen Pharmaceutical Co Ltd | 2 - [[[2 -[(hydroxyacetyl) amino]- 4 -pyridinyl] methyl]thio]- n -[4 - (trifluoromethoxy) phenyl]- 3 -pyridinecarboxamide benzene-sulfonate, crystal of same, polymorph thereof, and processes for production thereof |
| EP3158991B1 (en) * | 2010-01-28 | 2021-03-17 | Eagle Pharmaceuticals, Inc. | Formulations of bendamustine |
-
2014
- 2014-09-18 TW TW103132199A patent/TW201518291A/zh unknown
- 2014-09-18 KR KR1020167008149A patent/KR20160060656A/ko not_active Withdrawn
- 2014-09-18 JP JP2014190339A patent/JP5856264B2/ja not_active Expired - Fee Related
- 2014-09-18 SG SG11201602020QA patent/SG11201602020QA/en unknown
- 2014-09-18 CA CA2924628A patent/CA2924628A1/en not_active Abandoned
- 2014-09-18 US US15/023,207 patent/US20160228420A1/en not_active Abandoned
- 2014-09-18 EA EA201690621A patent/EA201690621A1/ru unknown
- 2014-09-18 WO PCT/JP2014/074698 patent/WO2015041294A1/ja not_active Ceased
- 2014-09-18 AU AU2014322111A patent/AU2014322111A1/en not_active Abandoned
- 2014-09-18 HK HK16109575.6A patent/HK1221407A1/en unknown
- 2014-09-18 MY MYPI2016000477A patent/MY163236A/en unknown
- 2014-09-18 MX MX2016003566A patent/MX2016003566A/es unknown
- 2014-09-18 CN CN201480051151.8A patent/CN105555271A/zh active Pending
- 2014-09-18 HK HK16108793.4A patent/HK1220632A1/zh unknown
- 2014-09-18 EP EP14845745.0A patent/EP3047850A4/en active Pending
- 2014-09-18 BR BR112016006153A patent/BR112016006153A2/pt not_active IP Right Cessation
-
2015
- 2015-12-10 JP JP2015240775A patent/JP2016094442A/ja active Pending
-
2016
- 2016-03-09 PH PH12016500461A patent/PH12016500461A1/en unknown
- 2016-03-17 IL IL244648A patent/IL244648A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112016006153A2 (pt) | 2017-08-01 |
| JP2015083565A (ja) | 2015-04-30 |
| JP2016094442A (ja) | 2016-05-26 |
| AU2014322111A1 (en) | 2016-04-07 |
| EA201690621A1 (ru) | 2016-07-29 |
| CN105555271A (zh) | 2016-05-04 |
| EP3047850A4 (en) | 2017-05-10 |
| HK1220632A1 (zh) | 2017-05-12 |
| SG11201602020QA (en) | 2016-04-28 |
| IL244648A0 (en) | 2016-04-21 |
| CA2924628A1 (en) | 2015-03-26 |
| JP5856264B2 (ja) | 2016-02-09 |
| HK1221407A1 (en) | 2017-06-02 |
| MY163236A (en) | 2017-08-30 |
| KR20160060656A (ko) | 2016-05-30 |
| WO2015041294A1 (ja) | 2015-03-26 |
| TW201518291A (zh) | 2015-05-16 |
| US20160228420A1 (en) | 2016-08-11 |
| PH12016500461A1 (en) | 2016-05-16 |
| EP3047850A1 (en) | 2016-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015008627A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
| MX2015008628A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
| MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
| MX2016015093A (es) | Derivados de acido boronico y sus usos terapeuticos. | |
| PH12015501993A1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
| PH12015502546B1 (en) | 3-(4-isobutyl-2-methylphenyl) propanal as perfume ingredient | |
| MY163187A (en) | Novel imidazo-oxazine compound or salt thereof | |
| PH12016500806A1 (en) | Urea derivative or pharmacologically acceptable salt thereof | |
| IN2015DN00598A (enExample) | ||
| PH12015500900B1 (en) | A stabilized pemetrexed formulation | |
| PH12017501539A1 (en) | Disacetoxytubulysin h and analogs thereof | |
| MX2015010106A (es) | Moduladores de la proteina activadora de 5-lipoxigenasa. | |
| PH12016500461A1 (en) | Polyethylene glycol-containing composition | |
| GEP201706760B (en) | Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same | |
| MX2018001517A (es) | Derivados sustituidos de guanidina. | |
| PH12015502665A1 (en) | Improvements in or relating to organic compounds | |
| MX2015008829A (es) | Momelotinib deuterado. | |
| MX2015016332A (es) | Inhibidores de alk biciclicos fusionados. | |
| NZ627473A (en) | Aryloxyacetamide compound and pesticide | |
| PH12015501146A1 (en) | Hydantoin derivative | |
| NZ717192A (en) | Anti-inflammatory tripeptides | |
| WO2014172363A3 (en) | Combretastatin analogs | |
| EA201690908A1 (ru) | Пиразолопиримидиновые соединения | |
| AU2016286071A8 (en) | Total synthesis of shishijimicin A and analogs thereof | |
| MX2015012610A (es) | Pacritinib deuterizado. |